Matthew R. Patterson, Chief Executive Officer at Audentes Therapeutics, Inc. (BOLD), sold 21,000 shares at $30.00 ($630K) on 2019-02-25, disclosed to the SEC on 2019-02-27.
Open-market sale of $630k BOLD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 4,000 | $120K | 19.0% |
| 2 | $30.00 | 17,000 | $510K | 81.0% |
| Total | $30.00 avg | 21,000 | $630K | 100% |
| Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |
| BOLD | SELL | 2018-07-05 | $5.6M | — | Filing → |